Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 24 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
231 24.5 months Metastatic hormone-refractory prostate cancer 4 Biologic therapy
University of Birmingham United Kingdom 5/2009
Treatment Details: Patients: This phase 2 study involved 312 men with metastatic hormone refractory prostate cancer. They ranged in age from 49 to 91 years old. Almost all (more than 90%) had previously been
 
232 24.5 months Recurrent GBM 4 Chemotherapy
Radiotherapy Division of Pisa University Hospital Italy 3/2009
Treatment Details: Patients: This phase 2 study involved 50 patients with recurrent glioblastoma. There were 31 men and 19 women. Their median age was 56.8 years, ranging from 30 to 76. Treatment: Patie
 
233 24.5 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
University of California-Los Angeles United States 2/2009
Treatment Details: Patients: This phase 3 study involved 1,053 patients with metastatic colorectal cancer. They ranged in age from 22 to 89 years of age. Treatment: All patients were treated with chemo
 
234 24.5 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
University Hospital of Besançon France 12/2013
Treatment Details: Patients: This phase 2 study involved 61 metastatic colorectal cancer patients with a median age of 63.6 years; 57% were male. Treatment: Patients were treated with the chemotherapy reg
 
235 24.3 months Mantle-cell lymphoma 4 Biologic therapy
The University of Texas M. D. Anderson Cancer Center United States 7/2012
Treatment Details: Patients: This phase 2 study involved 38 mantle-cell lymphoma patients. The median patient age was 64 years and 92% were male. Treatment: Patients were treated with the biologic therap
 
236 24.3 months Stage III NSCLC 5 Chemotherapy
Radiation
Lineberger Comprehensive Cancer Center, University of North Carolina United States 5/2008
Treatment Details: Patients: This phase II study involved 68 patients with non-small-cell lung cancer. The majority (75%) of patients were men. The median age was 61, ranging from 38 to 79 years old. Tre
 
237 24.1 months Metastatic colorecal cancer 4 Biologic therapy
Chemotherapy
Azienda Ospedaliera-Universitaria Pisana Italy 10/2013
Treatment Details: Patients: This study involved 15 metastatic colorectal cancer patients who had the BRAF genetic mutation. The median patient age was 56 years and 40% were male. Treatment: Patients wer
 
238 24.0 months Metastatic breast cancer 4 Chemotherapy
University of Pittsburgh Cancer Institute United States 6/2014
Treatment Details: Patients: This study involved 86 metastatic breast cancer patients with a median age of 53 years. Treatment: Patients received chemotherapy with capecitabine. Toxicities: The most
 
239 24.0 months NSCLC 4 Chemotherapy
Radiation
Third Affiliated Hospital of Harbin Medical University China 1/2015
Treatment Details: Patients: This study involved non-small cell lung cancer patients who were divided into two separate treatment groups. Group A had 20 patients with an average age of 59.6 years; 75% were m
 
240 24.0 months Metastatic breast cancer 3 Chemotherapy
Medical University of Vienna Austria 9/2007
Treatment Details: Patients: This study involved 40 women with metastatic breast cancer. The median age was 58.5 years, ranging from 29 to 73. All women previously had anthracycline and taxane or vinorelbin
 
Page 24 of 187  | Previous Page  | Next Page